72 results
8-K
EX-2.1
SRGAQ
Surgalign Holdings, Inc.
29 Sep 23
Bankruptcy or Receivership
4:15pm
with a legacy of clinically validated surgical device and biologic innovation stretching back 30 years. Since then, the Debtors have continued to invest … , with commercial, innovation and design centers in San Diego, California, Wurmlingen, Germany, Poznan, Poland, and Warsaw, Poland, the Debtors
8-K
EX-99.1
SRGAQ
Surgalign Holdings, Inc.
1 Aug 23
Surgalign Successfully Completes Auction and Names Successful Bidders For Asset Sales
5:19pm
distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland
8-K
EX-99.1
SRGAQ
Surgalign Holdings, Inc.
23 Jun 23
Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing
8:30am
. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland
8-K
EX-99.1
SRGAQ
Surgalign Holdings, Inc.
20 Jun 23
Entry into a Material Definitive Agreement
8:48am
, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Learn more at www.surgalign.com and connect
8-K
SRGAQ
Surgalign Holdings, Inc.
22 May 23
Termination of a Material Definitive Agreement
3:09pm
and innovation space in San Diego, California. The material terms of the Lease were included in Item 1.01 of the Current Report on Form 8-K filed
8-K
EX-99.1
a8w 3m6h37u0d0k8
11 May 23
Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations
4:06pm
8-K
EX-99.1
jmo9lozzmg
30 Mar 23
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results
4:06pm
424B5
zie8d2szyaz0h1jygdc
15 Nov 22
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
c8ojnq5hkokk70p2
15 Nov 22
Surgalign Announces $12.0 Million Registered Direct Offering
4:05pm
8-K
EX-99.1
dk2qfo
2 Nov 22
Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook
4:06pm
8-K
EX-99.1
c83wo4i
24 Aug 22
Surgalign Announces FDA 510(k) Clearance of the CorteraTM Spinal Fixation System – The Company’s New Flagship Posterior Fixation Platform
4:41pm
8-K
EX-99.1
5bl0j3fc8g5o
10 Aug 22
Surgalign Announces Global Settlement Agreement with Parties enter into new sole-source supply relationship, extended for two years
5:02pm
8-K
EX-99.1
pr24 9bn0
4 Aug 22
Surgalign Reaches Settlement with the Securities and Exchange Commission
5:38pm
8-K
EX-99.1
ccrj0nqql
16 May 22
Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split
6:06am
8-K
EX-99.1
qhcfdgea nqm
10 May 22
Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range
4:11pm